Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
04/2003
04/17/2003US20030073852 Anticancer agents
04/17/2003US20030073827 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
04/17/2003US20030073822 Blood group antigen fusion polypeptides and method of use thereof
04/17/2003US20030073810 Nucleotide sequence codin polypeptide for use in the diagnosis and treatment of nervous system and cancer disorders
04/17/2003US20030073655 Alzheimer's disease
04/17/2003US20030073653 Method for transferring nucleic acid into striated muscles
04/17/2003US20030073624 Anticancer agents; isolated nucleic acids; genetic engineering
04/17/2003US20030073620 Genetic engineering; antibody binding to nucleic acid; disease therapy
04/17/2003US20030073223 For use in vaccines
04/17/2003US20030073221 Hyaluronan synthase gene and uses thereof
04/17/2003US20030073199 Nucleotide sequences coding polypeptides for use in the treatment of rheumatic and rheumatoid arthritis
04/17/2003US20030073166 Haemophilus adherence and penetration proteins
04/17/2003US20030073162 Protein for use in the diagnosis, treatment and prevention of cancer
04/17/2003US20030073160 Compositions and methods for detecting stress-inducible proteins
04/17/2003US20030073141 Monoclonal antibodies against a complex of human ACT and a serine protease
04/17/2003US20030073102 Methods of MHC class II epitope mapping, detection of autoimmune T cells and antigens, and autoimmune treatment
04/17/2003US20030073095 Nucleotide sequences coding bacterial protein for use in the treatment and prevention of bacterial infections
04/17/2003US20030073094 Stress proteins and uses therefor
04/17/2003US20030073080 Genetically engineered viral nucleotide sequences for use as tool in gene therapy and vaccine development
04/17/2003US20030073076 Analyzing modulators or treatments of fibroproliferative diseases; obtain sample, incubate with modulator, monitor marker expression, decreased expression indicate effective modulator
04/17/2003US20030072826 Pine cone extracts and uses thereof
04/17/2003US20030072812 Administering at a tumor site in a mammalian subject a pharmaceutically acceptable form of at least one iron compound or complex in a suitable carrier for therapy of breast cancer
04/17/2003US20030072783 Administering nitric oxide adduct to a damaged vascular surface, wherein damaged vascular surface is interior surface of a blood vessel in which damage to endothelium or subendothelium, narrowing or stenosis of vessel has occured
04/17/2003US20030072775 For immunization; for therapy of disseminated candidiasis
04/17/2003US20030072774 Proteinaceous adjuvants
04/17/2003US20030072772 Sub-unit vaccine for infectious pancreatic necrosis virus
04/17/2003US20030072771 Porcine reproductive and respiratory syndrome vaccine, based on isolate JA-142
04/17/2003US20030072769 Used in the manufacture of vaccines, therapy, prophylaxis, drug screening
04/17/2003US20030072768 Method to enhance an immune response of nucleic acid vaccination
04/17/2003US20030072767 Compositions and methods for WT1 specific immunotherapy
04/17/2003US20030072766 Comprising antiserum raised against a flagellaless Campylobacter strain for prophylaxis of Campylobacter colonisation in animals
04/17/2003US20030072765 For therapy and prophylaxis of bacterial infections
04/17/2003US20030072764 Mucosal boosting following parenteral priming
04/17/2003US20030072763 Absorb in the low- energy, ultraviolet, visible, or near-infrared (NIR) region of the electromagnetic spectrum that are used for the phototherapy of tumors and other lesions
04/17/2003US20030072762 For enhancing Fc receptor-mediated antigen presentation, vaccines
04/17/2003US20030072760 Anti-estrogen and immune modulator combinations for treating breast cancer
04/17/2003US20030072759 Administering to a patient afflicted with a gastrointestinal tumor, a murine monoclonal antibody which specifically binds to an epitope of 17-1A antigen, the antibody being administered parenterally in multiple doses
04/17/2003US20030072754 CD154 blockade therapy for pancreatic islet tissue transplantation
04/17/2003US20030072753 Virus-like particles for the induction of autoantibodies
04/17/2003US20030072752 Two novel genes from psoriatic epidermis: psoriastatin type i and psoriastatin type ii
04/17/2003US20030072751 Idiotypic vaccination against b cell lymphoma
04/17/2003US20030072742 Enhancement of immune response using targeting molecules
04/17/2003CA2718802A1 Recombinant nucleic acids comprising regions of ad6
04/17/2003CA2471968A1 Immunostimulatory nucleic acids and use thereof
04/17/2003CA2462900A1 Reagents and methods useful for detecting diseases of the breast
04/17/2003CA2462862A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists
04/17/2003CA2462582A1 Adjuvants for nucleic acid vaccines
04/17/2003CA2461900A1 Leukocyte inactivation module
04/17/2003CA2461655A1 Nogo receptor-mediated blockade of axonal growth
04/17/2003CA2461435A1 Angiopoietin-2 specific binding agents
04/17/2003CA2461343A1 Mammalian c-type lectins
04/17/2003CA2461145A1 Live attenuated salmonella strains for producing vaccines
04/17/2003CA2461092A1 Pharmaceutical composition for the treatment of disorders of non-human mammals
04/17/2003CA2460480A1 Molecules for disease detection and treatment
04/17/2003CA2460476A1 Protein modification and maintenance molecules
04/17/2003CA2458645A1 Intracellular signaling molecules
04/17/2003CA2458464A1 Monoclonal and cdr-grafted antibodies specific for human kdr
04/17/2003CA2458392A1 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them
04/16/2003EP1301637A2 Dna vaccines encoding hiv accessory proteins
04/16/2003EP1301616A2 Bicistronic influenza viruses comprising two genes in tandem
04/16/2003EP1301615A2 Adenovirus vectors comprising introns
04/16/2003EP1301614A1 Codon-optimized papilloma virus sequences
04/16/2003EP1301611A2 Human rrp sequences and methods of use
04/16/2003EP1301606A1 Expression system
04/16/2003EP1301605A2 Nk cells activating receptors and their therapeutic and diagnostic uses
04/16/2003EP1301602A2 Fh-binding protein of streptococcus pneumoniae
04/16/2003EP1301541A2 Bifunctional molecules and vectors complexed therewith for targeted gene delivery
04/16/2003EP1301539A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
04/16/2003EP1301530A2 Multiple antigenic peptides immunogenic against streptococcus pneumoniae
04/16/2003EP1301524A1 B7-like polynucleotides, polypeptides, and antibodies
04/16/2003EP1301238A1 Vaccines
04/16/2003EP1301208A1 Vaccine
04/16/2003EP1301206A1 Treatment of central nervous system diseases by antibodies against glatiramer acetate
04/16/2003EP1301204A1 Immunological combinations for prophylaxis and therapy of helicobacter pylori infection
04/16/2003EP1301203A1 Vaccine comprising active agent immunogenic acyl glyceryl phosphatidylinositol manno-oligosaccharide
04/16/2003EP1301195A2 Pharmaceutical use of fibulin-1
04/16/2003EP1054691B1 Anti-enzyme antibodies for the treatment of the skin
04/16/2003EP1009442B1 Improvements in or relating to regulation of t cell activation
04/16/2003EP0869803B1 Allogeneic paracrine cytokine tumor vaccines
04/16/2003EP0868522B1 Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them
04/16/2003EP0789591B1 Methods for identifying individuals suffering from a cellular abnormality
04/16/2003EP0750508B1 RETROPEPTIDES, ANTIBODIES THERETO, AND USES THEREOF FOR VACCINATION AND $i(IN VITRO) DIAGNOSIS
04/16/2003EP0680338B1 Ganglioside-klh conjugate vaccines with qs-21
04/16/2003EP0654083B1 Ptp-d subfamily of protein tyrosine phosphatases
04/16/2003EP0648127B1 Type i surface antigens associated with staphylococcus epidermidis
04/16/2003EP0642356B1 Antibodies to p-selectin and their uses
04/16/2003EP0605442B1 Recombinant antibodies for human therapy
04/16/2003CN1411512A Chimeric immunogenic compositions and nucleir acids encoding them
04/16/2003CN1411505A Membrane virus host range mutations and their uses as vaccine stroma
04/16/2003CN1411468A Attenuated microorganisms for treatment of infection
04/16/2003CN1411378A Method for production of egg containing anti-pathogenic bacteria specific antibodies (IgY) and yogurt and ice cream containing IgY
04/16/2003CN1411376A Novel helicobacter pylori-binding substances and use thereof
04/16/2003CN1410535A Mandarin fish rhabdo virus toxic strain, its preparation method and application
04/16/2003CN1410534A Lefteye flounder lymph tumour virus toxic strain, its preparation method and application
04/16/2003CN1410533A Large brill rhabdo virus toxic strain and its preparation method and application
04/16/2003CN1410525A Preparation method trans hepatitis B surface antigen (HBsAg) gene salt algae
04/16/2003CN1410448A Terminal blocked pentahelicoprotein and its use
04/16/2003CN1410127A TB vaccine heat reversal protein65 and multiepi-position HER-2 Antigen fusion protein recombinat protein vaccine
04/16/2003CN1105728C Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
04/15/2003US6548643 Antigen carbohydrate compounds and their use in immunotherapy
1 ... 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 ... 1823